Published in Microbiol Immunol on January 01, 1979
Sequence of 3,687 nucleotides from the 3' end of Sendai virus genome RNA and the predicted amino acid sequences of viral NP, P and C proteins. Nucleic Acids Res (1983) 3.62
Determination of the complete nucleotide sequence of the Sendai virus genome RNA and the predicted amino acid sequences of the F, HN and L proteins. Nucleic Acids Res (1986) 2.60
Structural characterization of virion proteins and genomic RNA of human parainfluenza virus 3. J Virol (1984) 1.46
Nucleotide sequence of the bovine parainfluenza 3 virus genome: its 3' end and the genes of NP, P, C and M proteins. Nucleic Acids Res (1987) 1.34
Parainfluenza 3 virus: plaque-type variants lacking neuraminidase activity. Infect Immun (1981) 1.25
Neuraminidase activity and syncytial formation in variants of parainfluenza 3 virus. Infect Immun (1983) 1.12
Proteins associated with human parainfluenza virus type 3. J Virol (1985) 1.04
Acquisition of serum antibodies to specific viral glycoproteins of parainfluenza virus 3 in children. J Virol (1984) 1.02
Intracellular synthesis of human parainfluenza type 3 virus-specified polypeptides. J Virol (1985) 0.98
Experimental parainfluenzavirus infection in mice: fatal illness with atrophy of thymus and spleen in mice caused by a variant of parainfluenza 3 virus. Infect Immun (1982) 0.94
Serology of bovine parainfluenza virus type 3: comparison of the enzyme linked immunosorbent assay and hemagglutination inhibition. Can J Comp Med (1983) 0.80
Safety of inoculation of bovine parainfluenza virus 3 as potential vaccine vector in pigs. Virusdisease (2015) 0.75
Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol (1986) 37.70
Polyadenylic acid at the 3'-terminus of poliovirus RNA. Proc Natl Acad Sci U S A (1972) 5.42
Nuclear access and action of notch in vivo. Cell (1998) 4.98
Trans-activation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses. Proc Natl Acad Sci U S A (1986) 4.89
Congenital stationary night blindness with negative electroretinogram. A new classification. Arch Ophthalmol (1986) 3.90
Sequence of 3,687 nucleotides from the 3' end of Sendai virus genome RNA and the predicted amino acid sequences of viral NP, P and C proteins. Nucleic Acids Res (1983) 3.62
Mutational analysis of the human immunodeficiency virus vpr open reading frame. J Virol (1989) 3.48
Germline transformation of the silkworm Bombyx mori L. using a piggyBac transposon-derived vector. Nat Biotechnol (2000) 3.09
Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells. J Virol (1991) 3.05
Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles. J Virol (1993) 3.01
Requirements for presenilin-dependent cleavage of notch and other transmembrane proteins. Mol Cell (2000) 2.98
Productive, persistent infection of human colorectal cell lines with human immunodeficiency virus. J Virol (1987) 2.84
Early replication block of human immunodeficiency virus type 1 in monkey cells. J Gen Virol (1995) 2.73
Reduction of serum uric acid by hormone replacement therapy in postmenopausal women with hyperuricaemia. Lancet (1999) 2.71
Determination of the complete nucleotide sequence of the Sendai virus genome RNA and the predicted amino acid sequences of the F, HN and L proteins. Nucleic Acids Res (1986) 2.60
Replication of picornaviruses. I. Evidence from in vitro RNA synthesis that poly(A) of the poliovirus genome is genetically coded. J Virol (1975) 2.42
RNA packaging signal of human immunodeficiency virus type 1. Virology (1992) 2.38
Tumor necrosis factor-alpha (TNF-alpha) plays a protective role in acute viralmyocarditis in mice: A study using mice lacking TNF-alpha. Circulation (2001) 2.36
Cloning of monomeric human papillomavirus type 16 DNA integrated within cell DNA from a cervical carcinoma. J Virol (1986) 2.28
Production of human immunodeficiency virus (HIV)-like particles from cells infected with recombinant vaccinia viruses carrying the gag gene of HIV. Virology (1990) 2.24
Integration is essential for efficient gene expression of human immunodeficiency virus type 1. J Virol (1993) 2.22
Human papillomavirus type 16 transformation of primary human embryonic fibroblasts requires expression of open reading frames E6 and E7. J Virol (1989) 2.17
ParaSight-F test for the detection of treatment failure in multidrug resistant Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg (1996) 2.13
High incidence of urinary JC virus excretion in nonimmunosuppressed older patients. J Infect Dis (1990) 2.13
Purification and characterization of macrolide 2'-phosphotransferase from a strain of Escherichia coli that is highly resistant to erythromycin. Antimicrob Agents Chemother (1989) 2.05
Sequence studies of poliovirus RNA. III. Polyuridylic acid and polyadenylic acid as components of the purified poliovirus replicative intermediate. J Mol Biol (1975) 2.04
Mutational analysis of the human immunodeficiency virus type 2 (HIV-2) genome in relation to HIV-1 and simian immunodeficiency virus SIV (AGM). J Virol (1990) 1.99
Poly (A) and poly (U) in poliovirus double stranded RNA. Nat New Biol (1973) 1.95
Poly(U) in poliovirus minus RNA is 5'-terminal. Biochem Biophys Res Commun (1974) 1.88
Friedreich-like ataxia with retinitis pigmentosa caused by the His101Gln mutation of the alpha-tocopherol transfer protein gene. Ann Neurol (1997) 1.81
A mouse model of a human multiple GIST family with KIT-Asp820Tyr mutation generated by a knock-in strategy. J Pathol (2008) 1.78
Molecular characterization of a polymerase mutant human immunodeficiency virus. Virology (1987) 1.76
Schwannoma of the esophagus: a case exhibiting high 18F-fluorodeoxyglucose uptake in positron emission tomography imaging. Dis Esophagus (2009) 1.75
Characterization of the env gene and long terminal repeat of molecularly cloned Friend mink cell focus-inducing virus DNA. J Virol (1984) 1.71
Holter monitoring as a noninvasive indicator of cardiac involvement in sarcoidosis. Chest (1994) 1.69
Common neutralization epitope in minor capsid protein L2 of human papillomavirus types 16 and 6. J Virol (1999) 1.66
Overexpression of interleukin-6 aggravates viral myocarditis: impaired increase in tumor necrosis factor-alpha. J Mol Cell Cardiol (2001) 1.63
Homeobox protein Hex induces SMemb/nonmuscle myosin heavy chain-B gene expression through the cAMP-responsive element. Circ Res (2001) 1.61
Obesity and lipid profiles in middle aged men and women in Tanzania. East Afr Med J (2002) 1.60
Identification of a feline immunodeficiency virus gene which is essential for cell-free virus infectivity. J Virol (1992) 1.59
Soluble Nef antigen of HIV-1 is cytotoxic for human CD4+ T cells. FEBS Lett (1996) 1.56
Long terminal repeat of Friend-MCF virus contains the sequence responsible for erythroid leukemia. Virology (1985) 1.55
In vitro construction of pseudovirions of human papillomavirus type 16: incorporation of plasmid DNA into reassembled L1/L2 capsids. J Virol (1998) 1.55
Sequences responsible for erythroid and lymphoid leukemia in the long terminal repeats of Friend-mink cell focus-forming and Moloney murine leukemia viruses. J Virol (1987) 1.55
Function of human immunodeficiency virus type 1 Vpu protein in various cell types. J Gen Virol (1995) 1.52
Mutational analysis of human papillomavirus type 16 E7 functions. J Virol (1990) 1.52
Traditional Chinese medicine and Kampo: a review from the distant past for the future. J Int Med Res (2006) 1.52
Sphingosine 1-phosphate stimulates proliferation and migration of human endothelial cells possibly through the lipid receptors, Edg-1 and Edg-3. Biochem J (2000) 1.51
Syncytium formation by recombinant vaccinia viruses carrying bovine parainfluenza 3 virus envelope protein genes. J Virol (1989) 1.50
Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy. J Diabetes Complications (2001) 1.49
T-type calcium channel blockade as a therapeutic strategy against renal injury in rats with subtotal nephrectomy. Kidney Int (2008) 1.48
Determination of antipituitary antibody in patients with endocrine disorders by enzyme-linked immunosorbent assay and Western blot analysis. J Lab Clin Med (1998) 1.46
Serum level of vascular endothelial growth factor is decreased by hormone replacement therapy in postmenopausal women without hypercholesterolemia. Atherosclerosis (2000) 1.46
Human papillomavirus type 16 minor capsid protein l2 N-terminal region containing a common neutralization epitope binds to the cell surface and enters the cytoplasm. J Virol (2001) 1.44
Comparison of intrinsic activities of the putative sphingosine 1-phosphate receptor subtypes to regulate several signaling pathways in their cDNA-transfected Chinese hamster ovary cells. J Biol Chem (1999) 1.41
Thiodiglycolic acid as a possible causative agent of fixed drug eruption provoked only after continuous administration of S-carboxymethyl-L-cysteine: case report and review of reported cases. Br J Dermatol (2005) 1.41
Cardiovascular risk factors in Tanzania: a revisit. Acta Trop (2001) 1.40
Concomitant abdominal aortic aneurysm repair and cholecystectomy. Combination of retroperitoneal aortic reconstruction and gassless laparoscopic cholecystectomy. J Cardiovasc Surg (Torino) (2000) 1.39
Cultured epidermal-sheet graft for epidermodysplasia verruciformis. Lancet (1998) 1.39
A surface immunodeterminant of human papillomavirus type 16 minor capsid protein L2. Virology (1998) 1.38
Acute follicular graft-versus-host disease. Dermatology (1992) 1.38
Cell-dependent requirement of human immunodeficiency virus type 1 gp41 cytoplasmic tail for Env incorporation into virions. J Virol (2000) 1.38
The human immunodeficiency virus type 1 accessory protein Vpu induces apoptosis by suppressing the nuclear factor kappaB-dependent expression of antiapoptotic factors. J Exp Med (2001) 1.38
SIV/HIV recombinants and their use in studying biological properties. AIDS Res Hum Retroviruses (1992) 1.35
Two concomitant base substitutions in the putative replicase genes of tobacco mosaic virus confer the ability to overcome the effects of a tomato resistance gene, Tm-1. EMBO J (1988) 1.35
Nucleotide sequence of the bovine parainfluenza 3 virus genome: its 3' end and the genes of NP, P, C and M proteins. Nucleic Acids Res (1987) 1.34
A region of basic amino-acid cluster in HIV-1 Tat protein is essential for trans-acting activity and nucleolar localization. Virus Genes (1989) 1.33
Rapid emergence of mink cell focus-forming (MCF) virus in various mice infected with NB-tropic friend virus. Virology (1981) 1.32
Persistence of archetypal JC virus DNA in normal renal tissue derived from tumor-bearing patients. Virology (1992) 1.32
Human immunodeficiency virus Vpx is required for the early phase of replication in peripheral blood mononuclear cells. Microbiol Immunol (1994) 1.31
Typing of urinary JC virus DNA offers a novel means of tracing human migrations. Proc Natl Acad Sci U S A (1997) 1.30
Parent-to-child transmission is relatively common in the spread of the human polyomavirus JC virus. J Clin Microbiol (1995) 1.29
Growth efficiency of naturally occurring BK virus variants in vivo and in vitro. J Virol (1989) 1.29
Inhibitory effects of apple polyphenols and related compounds on cariogenic factors of mutans streptococci. J Agric Food Chem (2000) 1.29
Distribution of varicella-zoster virus strains carrying a PstI-site-less mutation in Japan and DNA change responsible for the mutation. Jpn J Exp Med (1989) 1.28
Functional comparison of transactivation by human retrovirus rev and rex genes. J Virol (1990) 1.27
Parainfluenza 3 virus: plaque-type variants lacking neuraminidase activity. Infect Immun (1981) 1.25
Strain variation of R5 direct repeats in the right-hand portion of the long unique segment of varicella-zoster virus DNA. J Virol (1988) 1.25
Phylogenetic analysis of dengue-3 viruses prevalent in Guatemala during 1996-1998. Arch Virol (2001) 1.23
Rescue of Sendai virus from viral ribonucleoprotein-transfected cells by infection with recombinant vaccinia viruses carrying Sendai virus L and P/C genes. Virology (1989) 1.23
Growth ability of human immunodeficiency virus type 1 auxiliary gene mutants in primary blood macrophage cultures. J Gen Virol (1994) 1.22
PPARs and their metabolic modulation: new mechanisms for transcriptional regulation? J Intern Med (2007) 1.21
Polyadenylate in the virion RNA of mouse hepatitis virus. J Biochem (1977) 1.21
Allelic recombination and linkage disequilibrium within Msp-1 of Plasmodium falciparum, the malignant human malaria parasite. Gene (1999) 1.21
Transmission of the human polyomavirus JC virus occurs both within the family and outside the family. J Clin Microbiol (1994) 1.20
Structure of a phosphorylated derivative of oleandomycin, obtained by reaction of oleandomycin with an extract of an erythromycin-resistant strain of Escherichia coli. J Antibiot (Tokyo) (1988) 1.18
Cloning and characterization of human MCM7 promoter. Gene (1998) 1.18
Immunohistochemical diagnosis of Cryptococcus neoformans var. gattii infection in chronic meningoencephalitis: the first case in Japan. Intern Med (2001) 1.17
Antiapoptotic activity of herpes simplex virus type 2: the role of US3 protein kinase gene. Microbes Infect (1999) 1.17
Moderate-intensity regular exercise decreases serum tumor necrosis factor-alpha and HbA1c levels in healthy women. Int J Obes Relat Metab Disord (2000) 1.17
The effect of the herbal medicine dai-kenchu-to on post-operative ileus. J Int Med Res (2002) 1.17
The human immunodeficiency virus long terminal repeat is preferentially expressed in Langerhans cells in transgenic mice. AIDS Res Hum Retroviruses (1989) 1.17
Nucleotide sequence of a Sendai virus genome region covering the entire M gene and the 3' proximal 1013 nucleotides of the F gene. Nucleic Acids Res (1984) 1.16